FDA Approves New Ready-to-Use Injectable for Chemotherapy Nausea

The FDA has granted approval for Azurity's Aprepitant Injectable Emulsion, a new ready-to-use intravenous treatment. This medication is designed to prevent chemotherapy-induced nausea and vomiting, offering a polysorbate-80-free option. The approval is expected to streamline preparation for healthcare providers and improve the overall patient experience.